Dupilumab-resistant facial erythema - Dermoscopic, histological and clinical findings of three patients

Allergol Int. 2021 Jan;70(1):156-158. doi: 10.1016/j.alit.2020.07.001. Epub 2020 Aug 4.

Authors

Mari Nakanishi¹, Risa Tamagawa-Mineoka², Yukiyasu Arakawa¹, Koji Masuda¹, Norito Katoh¹

Affiliations

¹ Department of Dermatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan.
² Department of Dermatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan. Electronic address: risat@koto.kpu-m.ac.jp.

PMID: 32768270
DOI: 10.1016/j.alit.2020.07.001

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Adult
Antibodies, Monoclonal, Humanized / therapeutic use*
Drug Resistance
Erythema / drug therapy*
Erythema / pathology
Face*
Female
Humans
Male
Middle Aged

Substances

Adrenal Cortex Hormones
Antibodies, Monoclonal, Humanized
dupilumab